MiMedx Group Inc (MDXG)
7.375
0.00 (0.00%)
USD |
NASDAQ |
May 06, 09:45
MiMedx Group Cash from Operations (Quarterly): 5.978M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.978M |
| December 31, 2023 | 10.26M |
| September 30, 2023 | 12.79M |
| June 30, 2023 | 7.775M |
| March 31, 2023 | -4.048M |
| December 31, 2022 | -5.624M |
| September 30, 2022 | 0.959M |
| June 30, 2022 | -3.005M |
| March 31, 2022 | -10.22M |
| December 31, 2021 | -3.232M |
| September 30, 2021 | 6.33M |
| June 30, 2021 | 1.599M |
| March 31, 2021 | -6.679M |
| December 31, 2020 | -10.27M |
| September 30, 2020 | -4.618M |
| June 30, 2020 | -3.097M |
| March 31, 2020 | -12.28M |
| December 31, 2019 | -23.12M |
| September 30, 2019 | -3.16M |
| June 30, 2019 | 2.13M |
| March 31, 2019 | -15.26M |
| December 31, 2018 | 1.534M |
| September 30, 2018 | 3.397M |
| June 30, 2018 | 20.69M |
| March 31, 2018 | 10.18M |
| Date | Value |
|---|---|
| December 31, 2017 | 20.86M |
| September 30, 2017 | 17.95M |
| June 30, 2017 | 13.48M |
| March 31, 2017 | 10.64M |
| December 31, 2016 | 14.70M |
| September 30, 2016 | 2.845M |
| June 30, 2016 | 7.28M |
| March 31, 2016 | -0.977M |
| December 31, 2015 | 4.356M |
| September 30, 2015 | 7.308M |
| June 30, 2015 | 2.933M |
| March 31, 2015 | 4.21M |
| December 31, 2014 | 8.286M |
| September 30, 2014 | 8.948M |
| June 30, 2014 | 1.18M |
| March 31, 2014 | -1.612M |
| December 31, 2013 | 0.8407M |
| September 30, 2013 | 1.729M |
| June 30, 2013 | -0.7554M |
| March 31, 2013 | -2.098M |
| December 31, 2012 | -0.8709M |
| September 30, 2012 | -0.8623M |
| June 30, 2012 | -0.3109M |
| March 31, 2012 | -1.288M |
| December 31, 2011 | -1.656M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-23.12M
Minimum
Dec 2019
12.79M
Maximum
Sep 2023
-2.077M
Average
-3.128M
Median
Cash from Operations (Quarterly) Benchmarks
| TELA Bio Inc | -11.05M |
| Amylyx Pharmaceuticals Inc | 13.55M |
| CEL-SCI Corp | -4.888M |
| AIM ImmunoTech Inc | -9.758M |
| IGC Pharma Inc | -1.587M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.024M |
| Cash from Financing (Quarterly) | -33.47M |
| Free Cash Flow | 29.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | 28.48M |
| Free Cash Flow to Firm (Quarterly) | 1.176M |
| Free Cash Flow Yield | 2.99% |